Skip to main content
Equibles

PRISMMEDI · PRISM MEDICO AND PHARMACY LTD. · Financials

Use PRISMMEDI with AI

Add company filings, earnings and prices to ChatGPT or Claude, then ask questions in your own chat.

Choose your app for step-by-step connection instructions. Sign in with Equibles when asked; no code or API key is needed.

Claude ChatGPT

After connecting, ask your AI to use Equibles to research PRISMMEDI.

Other apps & server URL
https://mcp.equibles.com/mcp
Gemini CLI setup
or ask here

Free, nothing to set up — ALVIS runs on the same tools and cites every figure.

See what you can ask in ChatGPT or Claude

All connection guides →
34.98 INR -0.32 (-0.91%) At close · Nov 13
Rebalance outlook locked
Market Cap
474.45M INR
Shares
13.56M
Volume · Nov 13 22.61K Avg daily vol (3M) 10.95K

Income-statement, balance-sheet and cash-flow figures read from the company's own published financial reports.

Pull these statements through the financial statements API or MCP →
Revenue
24.43M +286.7%
FY2026 Revenue FY2025–FY2026
Net Income
3.18M +753.8%
FY2026 Net Income FY2025–FY2026
Operating Cash Flow
17K +110.3%
FY2026 Operating Cash Flow FY2025–FY2026

Chart any reported metric, KPI or segment over time — the full statement history lives here

Income Statement Balance Sheet Cash Flow All Metrics
Annual Quarterly
Line Item TTM FY2026 FY2025
INR 5.37M 24.43M 6.32M
INR 27K 35K 42K
INR 7000 33K 17K
INR 317K 4.3M -658K
INR 1.18M 1.11M -171K
INR -861K 3.18M -487K
Values reflect the latest filing (restatements included); per-share figures on today's split basis. Click a value for its source filing. TTM: trailing twelve months through the latest reported quarter — flows sum the last four quarters, balances take the latest.

Capital Returned to Shareholders

Cash spent on share repurchases and dividends per fiscal year, as reported on the cash-flow statement. Across FY2025–FY2026: 0 in dividends.

Debt Profile

No verified debt profile is available yet. This does not establish that the company has no debt or covenants.